Sticta Biologicals

Sticta provides at-site production of yeast derived recombinant proteins and key nutrients for the cell-based meat industry
2021
6
Santiago Chile

Innovation

Industry Problem

Growth Medium for cultured meat is not fully developed

R&D Focus

Yeast for Cell Culture

Innovative Solution

Sticta uses custom serum-free culture media, including protein and ingredients for the mass production of cultured meats

Solution Effectiveness

Sticta’s metabolic engineering and fermentation engineering, accelerates the synthesis of recombinant proteins and key nutrients

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

$27.4K

Startup Stage

Early-Stage

Lead Investors

ProVeg Incubator

People

Founders

CEO

Products

Demo Product or Complete Product?

Development

Awards and Recognitions

Media Apperance

GreyB